Published in Women's Health Weekly, September 27th, 2001
The FDA granted the label change following review of the first-ever placebo-controlled study to examine the efficacy and tolerability of long-term pharmacotherapy of PTSD. Zoloft is currently the only medication approved for PTSD and is the most prescribed brand in the U.S. for the treatment of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly